John W. Hlywak, Jr. (Investors)             Jay Higham (Media/Physicians)
Senior Vice President & CFO                 President & COO
IntegraMed America, Inc.                    IntegraMed America, Inc.
(914) 251-4143                              (914) 251-4127
email:  jhlywak@integramed.com              email:jayhigham@integramed.com
        ----------------------                    ------------------------
Web Address:  http://www.integramed.com
              -------------------------



     INTEGRAMED AMERICA CONTRACTS WITH LEADING PHILADELPHIA FERTILITY CENTER



Purchase, NY, April 14, 2005 - IntegraMed America, Inc. (Nasdaq: INMD) today
announced an exclusive agreement with Philadelphia, Pennsylvania-based Abington
Reproductive Medicine, PC ("Abington") to be an Affiliate in the expanding
IntegraMed provider network. Under the terms of the agreement, Abington has
access to the Company's inventory of patient and business services, focusing
initially on IntegraMed Shared Risk Refund and IntegraMed Pharmaceutical
Services. Abington is a leading provider of fertility services in the
Philadelphia marketplace and provides an important new distribution channel for
IntegraMed.

The physicians of Abington - Jay S. Schinfeld, M.D., Stephen G. Somkuti, M.D.,
Ph.D., and Larry I. Barmat, M.D..are reproductive endocrinologists in Abington,
a suburb of Philadelphia. Abington Reproductive Medicine provides comprehensive
infertility and assisted reproductive technologies, as well as specialized
gynecological and endocrine services. These services include in vitro
fertilization, Egg Donor programs, Male Infertility Services, Autologous
Endometrial Coculture, PGD testing, intracytoplasmic sperm injections (ICSI),
assisted hatching and reproductive surgeries. At Abington Reproductive Medicine,
patients benefit from the latest in infertility research and techniques. Several
of these advanced techniques have been pioneered and perfected through their
ongoing research studies.

Under the terms of the agreement, IntegraMed is committed to providing Abington
with access to patient and business service offerings. Initially, the focus is
on the Company's Shared Risk Refund program, a powerful product that enables
consumers to pursue IVF treatment with a greater sense of financial security,
since, for a single fee, it provides access for up to 6 cycles of treatment,
with a substantive refund if the patient does not end up with a take-home baby.
With Shared Risk + Drug, the pharmaceuticals associated with IVF treatment are
available at a significant discount. In addition, Abington has the right to
access a full portfolio of other products and services that the Company makes
available to its growing network of affiliated fertility centers.

                                    - more -




"Philadelphia is a large metropolitan market for fertility services that we are
excited to add to our Northeast network," said Jay Higham, President and COO of
IntegraMed America, Inc. "As a leading fertility center in that area, our
contract with Abington Reproductive Medicine continues this company's tradition
of only working with the best and most influential physicians. We believe this
strategy helps to position IntegraMed as the leading provider of services to
prospective parents and medical providers in this field."

"We are excited to open this relationship with IntegraMed," said Jay Schinfeld,
MD. "As the director of reproductive endocrinology here at Abington Memorial, I
have seen many changes in this area of medicine - being able to offer Shared
Risk is a powerful way to open up the option of IVF treatment to more patients
seeking this type of treatment. And by affiliating with IntegraMed, we are proud
to add our names to a network of some of the top infertility specialists in the
country."


IntegraMed's network is now comprised of 24 contracted fertility centers. These
centers employ 131 physicians and PhD scientists in 71 locations across the
United States. They account for approximately 20% of total IVF volume performed
in this country with excellent success rates. This makes IntegraMed the leader
in providing services to both consumers and medical providers in the fertility
field.


IntegraMed, based in Purchase, NY offers products and services to patients,
providers and payors focused on the $2 billion fertility industry. IntegraMed
provides business services to a national network of fertility centers;
distributes pharmaceutical products and treatment financing programs directly to
consumers; and operates http://www.integramed.com, a leading fertility portal.

Statements contained in this press release that are not based on historical
fact, including statements concerning future results, performance, expectations
and expansion of IntegraMed are forward-looking statements that may involve a
number of risks and uncertainties. Actual results may differ materially from the
statements made as a result of various factors, including, but not limited to,
the risks associated with IntegraMed's ability to finance future growth; the
loss of significant business services contract(s); profitability at Reproductive
Science Centers serviced by IntegraMed; changes in insurance coverage,
government laws and regulations regarding health care or managed care
contracting; and other risks, including those identified in the IntegraMed's
most recent Form 10-K and in other documents filed by IntegraMed with the U.S.
Securities and Exchange Commission. All information in this press release is as
of April 14, 2005 and IntegraMed undertakes no duty to update this information.



                                    # # # #